Skip to content

New HIV fusion inhibitor: T-1249 appears as potent as T-20

ddI/d4T/abacavir: don't use it, say Danes

HIV Lipodystrophy Workshop: d4T/ddI cause more fat loss than AZT/3TC

Lipodystrophy too high a price for two years of extra life, say patients

Protease inhibitors impair mitochondrial function: another contributor to HIV lipodystrophy?

Study finds d4T use, but not total exposure to NRTIs associated with lipodystrophy

Controversial Thai “treatment” loses key supporter

Women at greatest risk of NNRTI rash

Protease inhibitors and heart disease - more evidence of risk